Purchase Order 36C25023P0088
Award Date
10/14/22
Potential Completion Date
12/30/22
Potential Value
$237K
Federal Agency
Veterans Integrated Service Network 10
Awardee
Travere Therapeutics, Inc.
Ultimate Awardee
Not listed
NAICS Category
325412 - Pharmaceutical Preparation Manufacturing
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
San Diego, CA 92130, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Department of Veterans Affairs Veterans Health Administration awarded a firm fixed price purchase order to Travere Therapeutics, Inc. to provide the drug CHENODAL 250MG (CHENODIOL) for $200,552 with a completion date of June 30, 2025. Travere Therapeutics is a biopharmaceutical company that specializes in rare disease therapies and has received prior federal contracts to supply pharmaceuticals like Thiola and Cholbam to the VA and other government agencies. This contract was awarded...
The Department of Veterans Affairs has awarded a $236,500.00 firm fixed price contract to Travere Therapeutics, Inc. to provide the pharmaceutical product Chenodal (chenodiol) 250mg. The contract has a period of performance through March 23, 2024 and was not set aside for any specific business category. Travere Therapeutics is a biopharmaceutical company that specializes in rare disease therapies and has received multiple awards from the VA and other government agencies to supply specialty...
This federal contract award was issued by the Department of Veterans Affairs (VA) Veterans Health Administration to Travere Therapeutics, Inc. for the delivery of the pharmaceutical product Chenodal. The firm fixed price purchase order, valued at $189,200.00, has a completion date of September 30, 2022. Travere Therapeutics is a biopharmaceutical company that specializes in rare disease therapies and has received numerous federal contract awards from the VA and other agencies to supply...
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 10 awarded a $236,500 firm fixed price purchase order to Travere Therapeutics, Inc. Travere Therapeutics, Inc. Division for the delivery of CHENODAL 250MG (CHENODIOL) pharmaceutical products. Performance will take place in Foster City, California over a one year period ending September 30, 2024. No subcontractors or set aside designations were indicated. This order for chenodiol, a medication...
This is a firm fixed-price purchase order awarded by the Department of Veterans Affairs (VA) to Travere Therapeutics, Inc., a biopharmaceutical company specializing in rare disease therapies. The contract, valued at $94,600.00, is for the delivery of the pharmaceutical product CHENDAL 250MG. The award is part of Travere's existing Federal Supply Schedule (FSS) contract for Pharmaceuticals and Drugs with the VA, and the company also holds a $25 million Blanket Purchase Agreement (BPA) with the VA...
This federal contract award was made by the Department of Veterans Affairs (VA) to Travere Therapeutics, Inc., a biopharmaceutical company specializing in rare disease therapies. The $212,584.00 firm fixed-price purchase order is for the delivery of pharmaceutical drugs, with a period of performance ending on September 30, 2025. Travere Therapeutics holds a Federal Supply Schedule (FSS) contract with the VA as well as two Blanket Purchase Agreements (BPAs) specifically covering the procurement...
This is a firm fixed-price delivery order award to Travere Therapeutics, Inc., a biopharmaceutical company, by the Department of Veterans Affairs (VA) Veterans Integrated Service Network 21. The contract is for the supply of Travere's specialty pharmaceutical product Filspari 400mg, which is used to treat rare diseases affecting kidney and liver function. The award has a ceiling value of $7,354.26 and a period of performance through September 30, 2024. Travere Therapeutics holds a Federal Supply...
This is a firm fixed-price delivery order awarded by the Department of Veterans Affairs to Travere Therapeutics, Inc., a biopharmaceutical company specializing in rare disease therapies. The contract provides for the supply of 30 tablets of Sparsentan 400mg, with 7 refills, at a ceiling value of $36,771.30. The order is issued against Travere's Federal Supply Schedule (FSS) contract for Pharmaceuticals and Drugs (FSS-61-IB) with the VA, which has a total potential value of up to...
This is a federal contract award issued by the Veterans Integrated Service Network 20 (VISN 20) of the U.S. Department of Veterans Affairs (VA) to Travere Therapeutics, Inc. The contract is for the delivery of the pharmaceutical product Filspari, with a ceiling value of $11,280.64 and a completion date of December 18, 2024. The contract is a Delivery Order under Travere's Federal Supply Schedule (FSS) contract with the VA for Pharmaceuticals and Drugs (FSS-61-IB). Additionally, Travere holds two...
This is a federal contract award to Travere Therapeutics, Inc., a biopharmaceutical company, for the delivery of the pharmaceutical product Thiola 100 mg. The contract, valued at $11,125.32, was awarded by the Department of Veterans Affairs (VA) Veterans Integrated Service Network 5 (VISN 5) on August 26, 2024, with an ultimate completion date of August 27, 2024. The contract is a firm fixed price delivery order issued under Travere's Federal Supply Schedule (FSS) contract with the VA for...